BRINZOLAMIDE / BRIMONIDINE (Simbrinza®) eye drops

Clinical Indication

Glaucoma

Date of classification

August 2015

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.